The ICGAC will oversee and provide expertise in updating the Australian Guidelines for the Prevention and Control of Infection in Healthcare (2010 Guidelines) to ensure it reflects the best available evidence and is current and relevant for the Australian context.
The ICGAC is an advisory committee established by a CEO delegate, under section 39 of the National Health and Medical Research Council Act 1992.
Appointment Process for the Committee
The committee was selected to ensure appropriate expertise in the key areas of infectious diseases, antimicrobial resistance and/or microbiology, healthcare associated infection, paediatrics, evidence-based methodologies (e.g. epidemiology, systematic review methodology), inflection control in a dental setting, Aboriginal and Torres Strait Islander health and consumer representation.
Terms of Reference
The ICGAC will oversee and provide expertise in updating the Australian Guidelines for the Prevention and Control of Infection in Healthcare (2010 Guidelines) to ensure it reflects the best available evidence and is current and relevant for the Australian context. As per the 2010 Guidelines, the updated guidelines will aim to promote and facilitate the overall goal of infection prevention and control: ‘The creation of safe healthcare environments through the implementation of practices that minimise the risk of transmission of infectious agents’.
The ICGAC will:
- Determine the scope of the guideline update based on consideration of:
- the currency, accuracy and relevance of the existing 2010 Guidelines;
- feedback provided by the broader community and healthcare sector on the 2010 Guidelines, including new areas for potential inclusion;
- the results of a horizon scan funded by the Australian Commission on Safety and Quality in Health Care (the Commission), that identifies and assesses the quality of guidelines published since the 2010 Guidelines;
- committee member’s knowledge/expertise of current evidence or practice in infection prevention and control in Australia; and
- any other information deemed relevant by the Office of NHMRC or the Commission.
- Advise on the evidence evaluation required to update the 2010 Guidelines by:
- identifying and prioritising topics requiring the identification of new evidence published since the search period for the 2010 Guidelines; and
- advising on the scope and clinical questions for the evaluation/s, and methods to identify and evaluate relevant evidence.
- Oversee the update of the 2010 Guidelines by considering (1) and (2) above. This may include, but is not limited to providing advice on:
- developing recommendations using NHMRC’s preferred method;
- key stakeholders to be included in consultation activities; and
- comments received during consultation and expert review on the draft revised Guidelines.
The ICGAC will report to NHMRC’s Council.
Appointments to the ICGAC commenced on 25 January 2016 and will be effective until 31 March 2019.
Contact the ICGAC
Infection Control Guidelines Team
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
Email address: email@example.com
Please note: Members of the ICGAC are unable to respond to individual enquiries.
Member information and Disclosure of Interests
NHMRC asked each Infection Control Guideline Advisory Committee member to document their interests, as part of the process of the establishment of any NHMRC committee. Members were asked to consider perceived interests as well as real interests.
Members were specifically asked to identify, to the best of their ability, interests relating to infection control guideline work including:
- relevant financial activities;
- relevant professional or organisational experience; and
- other relationships or activities.
Throughout the project members are required to inform NHMRC of any changes to their interests, and management strategies are put in place as needed.
Professor of Nursing, Faculty of Nursing and Health and Director Lifestyle Research Centre – Avondale College.
Relevant experience: Infection Prevention and Control
- Editor-in-Chief of Infection, Disease and Health
- Undertaking consultancy work for the Australian Commission on Safety and Quality in Health Care (Clostridium difficile infection) - Undertaken consultancy work on behalf of DFAT, exploring infection control issues in Daru, Papua New Guinea
- Recipient of an professional associated awarded research grant (Australasian College of Infection Prevention and Control), exploring the impact of urinary tract infections
- Recipient of an industry supported research grant (Covidien), exploring the relationship between hospital staffing and infections
- During 2015 and 2016, an invited speaker at the Australasian College for Infection Prevention and Control 4th international conference (Hobart); Infection Prevention Society National Conference (Harrogate, UK); Research workshop exploring the visualisation of infections (Glasgow, UK); Clinical Excellence Commission CAUTI Launch (Sydney)
- I was a member of the previous NHMRC Infection Control Guidelines Committee, responsible for developing the 2010 guidelines
- I have worked, undertaken work or had the following relationships: - Peer review of HAI surveillance publications developed by the Tasmanian Infection Prevention and Control Unit (DHHS) - Scientific Chair for the Australasian College for Infection Prevention and Control international conference in 2015 and 2016
- Member of the Australasian College for Infection Prevention and Control Research Committee
- Member of the Australian Commission on Safety and Quality in Health Care Technical Advisory Group
Professor of Infectious Diseases Epidemiology and the Director of Infection Prevention and Healthcare Epidemiology Unit at Alfred Health.
Relevant experience: Infectious Disease Physician and Epidemiology.
- I am Director of the Infection Prevention and Healthcare Epidemiology Unit at Alfred Health. My institution has received funding from Merck, GSK, Biocryst, George Clinical and Gilead to perform industry sponsored research - I have not received any funding directly or indirectly to participate in these studies. I receive NHMRC funding (Career Development Fellowship). I am participating in a contract with the Australasian Cochrane Centre to perform a systematic review commissioned as part of the IC Guidelines.
Executive Director, ACT Pathology; Infectious Diseases Physician and Microbiologist - Canberra Hospital and Professor, Medical School at the Australian National University.
Relevant experience: Infectious Disease Physician, Clinical Microbiology and Antimicrobial Resistance.
No interests to declare. I am the Patron and a member of the Australian College of Infection control and Prevention
Infection Prevention and Control Consultant, Western Diagnostics Pathology; Member, Australasian College for Infection Prevention and Control.
Relevant experience: Infection Prevention and Control.
- Employment: Since November 1994 -Infection Prevention and Control Consultant, Western Diagnostic Pathology, Western Australia and Northern Territory
- (Ongoing) membership Australasian College for Infection Prevention and Control
Senior Staff Specialist Microbiology and Infectious Diseases – Concord Hospital; Clinical Associate Professor, Department of Microbiology and Infectious Diseases – University of Sydney.
Infectious diseases, Microbiology and Antimicrobial Resistance
- Pharmaceutical Industry advisory board membership - Novartis (2010), Pfizer (2010-2014) Astra-Zeneca X (2011-2015), MSD (2013-2016)
- Consultancy fees - Juno Pharmaceuticals (2014-2015) for pharmaceutical submission to TGA
- Has received travel support and meal provision to attend Health Care Infection Advisory meetings held by Bio-Merieux (2011-2015)
Senior Project Officer – Australian Commission on Safety and Quality in HealthCare.
Relevant experience: Implementation
- Full time employment at the Australian Commission on Safety and Quality in HealthCare
- External evaluator for Australian Catholic University (2016)
- SHEA International Ambassador (2016)
- Invited to present at 4th ACIPC conference. Hobart 2015
- Conjoint lectureship at the University of New South Wales (UNSW) (2014-Current)
- Member of the Scientific Organising Committee for the Australasian College of Infection Prevention and Control (2016)
Infection Control Consultant; Infection Control Nurse Advisor – South Australian Health; Member of the Commission’s National Hand Hygiene Advisory Committee.
Note: Ms Henderson was a member of the Infection Control Guidelines Advisory Committee (ICGAC) until November 2017.
Relevant experience: Healthcare Associated Infections
- No interests to declare
Senior Clinical Lecturer – School of Dentistry at the University of Adelaide; Clinical Examiner – Australian Dental Council; Clinical Supervisor; Chair, Infection Control Committee – Australian Dental Association.
Relevant experience: Dental
- Director and Consultant, Special Needs Dental Unit, Adelaide Dental Hospital Frome Road Adelaide
- Principal Dentist and Specialist Special Needs Dentistry for Health Partners Dental
- I am often asked to provide lectures on a range of topics related to Special needs Dentistry including, blood borne virues (HIV, HCV), infection control, oral health during oncology care etc
- HE-023 committee (Processing of Medical and Surgical Instruments committee) member for Standards Australia
- Chair, Infection Control Committee, Australian Dental Association
- I have published minimally on a small range of topics related to special needs dentistry. Most recently on oral health in HIV
- Dental Advisor, Determining Authority, Professional Services Review Agency
Assistant Director of Nursing – Gold Coast Hospital and Health Service
Relevant experience: Healthcare Associated Infections and Nursing
- Queensland Nursing Council: research grant 2001
- Covidien Infection Control Research Grant 2012
- Member Infection Control Practitioners Association of Queensland (ICPAQ) 1993-2011 and held positions on executive committee
- Member Australian Infection Control Association (AICA) 1993-2011 and held positions on executive committee
- Member Australasian College of Infection Prevention and Control (ACIPC - formerly AICA) since 2012. Member of ACIPC Executive Council since November 2015
- Member of AICA/ACIPC Credentialing and Professional Standards (CAPS) Committee at various intervals since 2000. Currently Chair of CAPS since November 2015
- Member Implementation Advisory Committee, Australian Commission on Safety and Quality in Healthcare, healthcare-associated infection program 2007-2010
- Published in the area of infectious diseases in healthcare
- Member Queensland Nurses Union of Employees
- Member Healthcare Infection Editorial Board and Associate Editor 2010-2015
- Member Health, Infection and Disease Editorial Board current
- Financial member Association of Professionals in Infection Control (APIC) since 2007
- Guest reviewer American Journal of Infection Control (AJIC)
- Adjunct Lecturer Griffith University 2012-current (unpaid)
Program Manager, Healthcare Associated Infection Unit, Communicable Disease Control Directorate – Department of Health (Western Australia)
Relevant experience: Implementation
- No interests to declare
Deputy Head, Child Health Division, Menzies School of Health Research; Editor, Acute Respiratory Infections Group of The Cochrane Collaboration.
Relevant experience: Aboriginal and Torres Strait Islander Health, Paediatrics and Evidence Based Practice
- Employed as Senior Staff Specialist and Director of Paediatric Education at Royal Darwin Hospital and Deputy Head, Child Health Division, Menzies School of Heath Research
- I have participated in Advisory Boards on conjugate pneumococcal vaccines and chronic suppuratives otitis media for GlaxoSmithKline (no personal payment involved)
- I have received research funding from GlaxoSmithKline (protocol codes 113313 and 116164) Biologicals and Pfizer (reference no. Ws2382560) for investigator led research studies on the impact conjugate pneumococcal vaccines (no personal payment involved)
- Clinical Guidelines for the Medical Management of Otitis Media in Aboriginal and Torres Strait Islander children
- I have been an invited speaker for GlaxoSmithKline at a conference and presented on respiratory illness in Australian Aboriginal children
Active in both state and national health issues from a consumer/community stand point; A member on numerous healthy committees in New South Wales; previous member of the Board – Australasian College of Infection Prevention and Control.
Relevant experience: Consumer Representative
- Member of the Steering Committee for the Renewal Implementation Project, SCRIP (DOH, cervical screening)
- Member of the Community Council Northern Sydney Health Network (PHN)
- Travel and accommodation costs paid to attend Annual Conference of ACIPC in November 2015 in Hobart
Research Fellow, Deakin/Alfred Centre for Quality and Patient Safety Research (until 2018).
Director, Cabrini Monash University Department of Nursing Research (from 2019)
Relevant experience: Infection Prevention and Epidemiology
- Executive Member of the Australasian College for Infection Prevention and Control (ACIPC)
- Member of the Healthcare Infection Advisory Committee of the Australian Commission for Safety and Quality in Health Care since 2009
- Chair of the Research Committee of the Australasian College for Infection Prevention and Control (ACIPC) since 2014
- Editorial Board Member and Reviewer, Infection, Disease and Health (previously HealthCare Infection) journal since 2014
- Member of Scientific Committee, Australasian College for Infection Prevention and Control 2015 and 2016 Conference